BCM
WHWK

Bridgeway Capital Management’s Whitehawk Therapeutics WHWK Stock Holding History

Bridgeway Capital Management’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$757K Sell
165,284
-50,000
-23% -$208K 0.01% 787
2026
Q1 		$743K Hold
215,284
– – 0.01% 759
2025
Q4 		$521K Hold
215,284
– – 0.01% 813
2025
Q3 		$409K Sell
215,284
-100,000
-32% -$184K 0.01% 846
2025
Q2 		$590K Hold
315,284
– – 0.01% 746
2025
Q1 		$561K Buy
315,284
+199,884
+173% +$522K 0.01% 728
2024
Q4 		$364K Buy
115,400
+22,100
+24% +$50.1K 0.01% 880
2024
Q3 		$192K Buy
+93,300
New +$151K ﹤0.01% 1076

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bridgeway Capital Management's WHWK Position: Q2 2026 in Review

Bridgeway Capital Management reduced its Whitehawk Therapeutics (WHWK) stake by 23% in Q2 2026, selling an estimated $208K and leaving 165,284 shares worth $757K. The position accounts for 0.01% of the portfolio, ranked #787.

Bridgeway Capital Management first reported a position in WHWK in Q3 2024 and has held it in 8 quarters since. 77 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • Bridgeway Capital Management held 165,284 shares of Whitehawk Therapeutics worth $757K as of Q2 2026.
  • Bridgeway Capital Management sold 50,000 Whitehawk Therapeutics shares in Q2 2026, an estimated $208K.
  • Whitehawk Therapeutics made up 0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #787 holding.
  • Bridgeway Capital Management first reported a position in Whitehawk Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 77 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.